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Abstract: Although known for their potent venom and ability to prey upon both 
invertebrate and vertebrate species, the Barychelidae spider family has been entirely 
neglected by toxinologists. In striking contrast, the sister family Theraphosidae (commonly 
known as tarantulas), which last shared a most recent common ancestor with Barychelidae 
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over 200 million years ago, has received much attention, accounting for 25% of all the 
described spider toxins while representing only 2% of all spider species. In this study, we 
evaluated for the first time the venom arsenal of a barychelid spider, Trittame loki, using 
transcriptomic, proteomic, and bioinformatic methods. The venom was revealed to be 
dominated by extremely diverse inhibitor cystine knot (ICK)/knottin peptides, accounting 
for 42 of the 46 full-length toxin precursors recovered in the transcriptomic sequencing. In 
addition to documenting differential rates of evolution adopted by different ICK/knottin 
toxin lineages, we discovered homologues with completely novel cysteine skeletal 
architecture. Moreover, acetylcholinesterase and neprilysin were revealed for the first time 
as part of the spider-venom arsenal and CAP (CRiSP/Allergen/PR-1) were identified for 
the first time in mygalomorph spider venoms. These results not only highlight the extent of 
venom diversification in this neglected ancient spider lineage, but also reinforce the idea 
that unique venomous lineages are rich pools of novel biomolecules that may have 
significant applied uses as therapeutics and/or insecticides. 
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1. Introduction 
In contrast to “modern” spiders (infraorder Araneomorphae), spider families in the infraorder 
Mygalomorphae have many characteristics that are considered primitive including large paraxial fangs 
and a complete reliance on book lungs for atmospheric gas exchange [1,2]. The family Barychelidae 
comprises 44 genera and 307 extant species [3] accounting for 11% of all mygalomorphs, making it 
one of the most taxonomically diverse mygalomorph spider families. However, in striking contrast 
with their over 200 million year old sister family Theraphosidae (commonly termed “tarantulas”), 
which is probably the most thoroughly studied spider family with venom gland transcriptomes of 
several species already examined [4–7], barychelids have so far been entirely neglected by 
toxinological research. Over 200 peptide toxins have been described from theraphosid venoms 
(accounting for 25% of all described spider toxins while representing only 2% of all spider species) [8], 
whereas not even a single barychelid venom has been examined to date. 
Spider venoms in general are complex mixtures of salts, low molecular mass compounds, 
acylpolyamines, peptide toxins, and enzymes [9,10]. Primitive spider venoms such as those of 
theraphosids are dominated by cystine-knotted peptide toxins (“knottins”) with molecular masses of  
3–7 kDa that mainly act as modulators of ion channels to provide rapid incapacitation of prey [5,11]. 
Since they are closely related to theraphosids with a common ancestor dating back to the Triassic [12], 
one might assume a similar overall composition for barychelid venoms. However, it remains to be 
examined whether barychelid venoms have evolved novel peptide-toxin scaffolds and/or novel venom 
components with new modes of action during the 200 million years of independent evolution since 
their divergence from theraphosids. 
Recently, spider-venom peptides have been suggested as leads for the development of novel 
therapeutics [13] and insecticides [14]. Hence, the identification of novel structural scaffolds from 
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barychelid venoms might add to the pool of already known spider-toxin scaffolds, thereby increasing 
the chances of selecting useful lead candidates for insecticide and/or drug development. In order to 
unravel some of these hidden treasures, we have studied the venom gland proteome of the Australian 
barychelid Trittame loki using a combination of transcriptomic, peptidomic and bioinformatic 
methods. We present the first toxin sequences from barychelid venom, which includes novel cysteine 
scaffolds, thus providing new insights into the evolution of spider venoms. 
2. Results and Discussion 
Figure 1. Magnetic resonance imaging of Trittame loki venom glands. 
 
Magnetic resonance imaging (MRI) revealed that T. loki retained the primitive characteristic of 
large fangs and venom glands contained entirely within the massive chelicerae (Figure 1). 
Transcriptomics recovered six toxin types: 42 diverse isoforms of the classic ICK/knottin  
spider-venom peptides (Figure 2); variants of the previously characterised prokineticin family  
(Figure 3) [15,16], CAP (CRiSP/Allergen/PR-1) (Figure 4) and kunitz (Figure 5) domain proteins, 
with CAP sequenced for the first time from any mygalomorph spider, and the first discovery of the 
enzymes acetylcholinesterases (Figure 6) and neprilysin (Figure 7) in spider venom. Proteomics 
confirmed that each toxin type was translated and present in the secreted venom  
(Supplementary Table 1), except for kunitz which was not detected by mass spectrometry. 
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Figure 2. Phylogenetic reconstruction of Trittame loki and related inhibitor cystine knot 
(ICK)/knottin peptide toxins, conserved ancestral cysteines are shown in black, newly 
evolved cysteines are in red. Sequences obtained in this study are in green. Signal peptides 
are shown in lowercase. 
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Figure 3. Sequence alignment of spider venom colipase venom peptides: (1) Trittame loki 
COLIPASE-1; (2) D2Y2E5 Haplopelma hainanum; (3) Q5D233 Hadronyche infensa;  
(4) Q5D231 Hadronyche sp. (strain 20); (5) Q5D232 Hadronyche sp. (strain 20);  
(6) B1P1J0 Chilobrachys jingzhao; and (7) B1P1J2 Chilobrachys jingzhao. Signal peptides 
are shown in lowercase. 
 
Figure 4. Sequence alignment of spider venom CAP (CRiSP/Allergen/PR-1) venom 
peptides: (1) Trittame loki CAP-1; and (2) A9QQ26 Lycosa singoriensis. Signal peptides 
are shown in lowercase. 
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Figure 5. Sequence alignment of spider venom kunitz venom peptides: (1) Trittame loki 
KUNITZ-1; and (2) E7D1N7 Latrodectus hesperus. Signal peptides are shown  
in lowercase. 
 
Figure 6. Sequence alignment of the Trittame loki venom acetylcholinesterase and the 
non-venom homologue P56161 Anopheles stephensi. Signal peptides are shown  
in lowercase. 
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Figure 7. Sequence alignment of the Trittame loki venom neprilysin and the snake venom 
convergent neprilysin homologue T1E4Z0 Crotalus horridus. Signal peptides are shown  
in lowercase. 
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Table 1. Molecular evolution analyses of Trittame loki major ICK toxin clades. 
  
SLAC a FEL b REL c MEME d FUBAR e 
Integrative f 
BSR g 
PAML h 
SLAC + FEL + REL + MEME M8 M2a 
Clade I 
ω > 1 i 0 2 22 
2 sites 
13 22 
3 
17 12 
ω < 1 j 0 4 0 0 4 (9 + 8) (6 + 6) 
ω = 1.41 - 1.62 - - 1.81 1.81 
Clade II 
ω > 1 i 0 0 0 
0 sites 
0 0 
4 
5 3 
ω < 1 j 3 11 0 14 15 (1 + 4) (1 + 2) 
ω = 0.42 - 0.47 - - 0.67 0.67 
Legend: a: Single Likelihood Ancestor Counting; b: Fixed-effects likelihood; c: Random-effects likelihood; d: Sites detected as experiencing episodic diversifying selection 
(0.05 significance) by the Mixed  Effects Model Evolution (MEME); e: Fast Unconstrained Bayesian AppRoximation; f: Sites detected in common by SLAC, FEL, REL, 
MEME and FUBAR (the integrative approach); g: Number of branches detected by the branch-site REL (Random effects likelihood) test as episodically diversifying;  
h: Positively selected sites detected by the Bayes Empirical Bayes approach implemented in M8 and M2a. Sites detected at 0.99 and 0.95 significance are indicated in the 
parenthesis; i: Number of positively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor (for REL); or number of sites under pervasive diversifying 
selection at 0.9 posterior probability (FUBAR); j: Number of negatively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor (for REL); or number of 
sites under pervasive purifying selection at 0.9 posterior probability (FUBAR); ω: mean dN/dS. 
Toxins 2013, 5 2496 
 
 
The most abundant transcript type was of the ICK/knottin neurotoxic peptide type which showed 
significant evidence of accelerated evolution and diversification. This diversity was accompanied by 
extensive variation in cysteine pattern including multiple independent de novo evolution of novel 
cysteines (Figure 2). These peptides were phylogenetically diverse, with the T. loki ICK/knottin toxins 
forming eight clades, with two of them being particularly large and divergent (Figure 2). Notably the 
first of the major clades of ICK peptides also had a pair of newly evolved cysteines, as did less diverse 
sets. We assessed the molecular evolutionary history of genes encoding these toxins using state-of-the-art 
selection assessment methods The one-ratio model, the simplest of the lineage-specific models, 
estimated an ω of 1.36 and 0.46 for the major ICK/knottin toxin clades 1 and 2, respectively 
(Supplementary Tables 2.1 and 2.2). This highly conservative model can only detect positive selection 
when the ω ratio, averaged over all sites along the lineages in a phylogenetic tree, is significantly 
greater than one. Hence, the ω of 1.36 estimated for the major ICK/knottin toxin clade 1 clearly 
highlights the dominant role of positive selection in shaping their evolutionary history. Since  
lineage-specific models often fail to detect episodic diversifying selection that only affects certain sites 
in protein-encoding genes, we further employed site-specific models (Table 1 and Supplementary 
Tables 2.1 and 2.2). Model 8 estimated an ω of 1.81 and 0.67 for the major ICK/knottin toxin clades 1 
and 2, respectively, highlighting the significant influence of positive selection on the evolution of the 
major ICK/knottin toxin clade 1 (Table 1 and Supplementary Tables 2.1 and 2.2). In contrast to the 
rapidly evolving clade 1, an ω of 0.67 estimated for the ICK/knottin toxin clade 2 indicated that this 
toxin clade has evolved under significant constraints of negative selection pressure and that the major 
part of its coding sequence has remained extremely well conserved over evolutionary time. The Bayes 
Empirical Bayes (BEB) method identified as many as 17 (33% of sites) positively selected sites in the 
major ICK/knottin toxin clade 1 and detected only 5 (11% of sites) positively selected sites in toxin 
clade 2 (Table 1 and Supplementary Tables 2.1 and 2.2), further highlighting the differential influence 
of evolutionary selection pressures on these two toxin clades. Other methods of evaluating the nature 
of selection, such as FEL, REL, MEME, FUBAR and integrative approach, conclusively supported 
these findings and indicated that in contrast to the rapidly evolving clade 1, clade 2 remains extremely 
well conserved (Table 1). 
With a combined nucleotide and amino acid-level approach, we were able to identify seven and five 
positively selected sites in the major ICK/knottin toxin clades 1 and 2, respectively (Supplementary 
Table 3). Interestingly, all five hypermutational sites identified in clade 2 were extremely varied in 
terms of biochemical and/or structural properties, relative to their ancestral residues. Radical mutations 
are more likely to influence the fitness of the organism, since they are capable of altering the structure 
and/or function of the protein, in contrast to neutral mutations that result in the introduction of residues 
with similar biochemical properties. Evolutionary fingerprint analyses clearly depicted several residues 
in the major ICK/knottin toxin clade 1 as evolving under the influence of positive selection, while a 
majority of sites in the toxin clade 2 were found to be evolving under the regime of negative-selection 
(Supplementary Figure 1). The branch-site REL test detected 4 and 3 branches respectively in the two 
major ICK/knottin toxin clades as evolving under episodic bursts of adaptation (Supplementary Figure 2). 
Thus, the evidence provided by various analyses, such as codeml site and lineage-specific models 
(M8, M2a, M3 and M0), various models of HyPhy (SLAC, FEL, REL, MEME and FUBAR), the 
amino acid-level approach implemented in TreeSAAP, the evolutionary fingerprint analyses and 
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branch-site REL (Table 1; Supplementary Tables 2.1, 2.2 and 3; and Supplementary Figures 1 and 2), 
clearly highlighted the differential rate of evolution adopted by the major ICK/knottin toxin clades and 
is indicative of extreme venom diversification in the barychelid spider T. loki. The major ICK/knottin 
toxin clade 1 in particular was found to have evolved under the significant influence of positive 
selection, while most codon sites in clade 2 evolved under the regime of negative selection and thus 
remained well conserved. We speculate that the lack of variation in toxin clade 2 might be the result of 
selection pressures exerted by their target receptors in the form of steric requirements that influence 
binding efficiency. The conspicuous rapid accumulation of variations under the influence of positive 
Darwinian selection in the major ICK/knottin toxin clade 1 is strongly suggestive of its role in prey 
envenoming. We propose that these toxins are highly likely to play a central role in prey-envenoming 
and capture, and are likely to be involved in a co-evolutionary predator-prey arms race with their 
molecular targets in prey animals. A handful of positively selected sites were detected in the coding 
sequences of ICK/knottin toxin clade 2, indicating that even these highly conserved toxins accumulate 
variations, probably to fine-tune their biochemical activities. Not-surprisingly, we identified a large 
number of novel cysteine variants in this rapidly evolving ICK/knottin peptide toxin class (Figure 2), 
pointing towards potential wide scale neofunctionalisation. Experimental examinations are warranted 
to precisely understand the stark difference in the evolutionary regimes adopted by the aforementioned 
toxin clades. 
Our identification of enzymes like acetylcholinesterase and neprilysin in the venom of spiders 
points to a more complex spider-venom arsenal than previously realised. It is noteworthy that, as 
indicated by the proteomic data (Supplementary table 1), these enzymes are not just present in trace 
amounts in the venom. This, together with the lack of identification of other proteins with potentially 
metabolic roles in the venom, suggests that both acetylcholinesterase and neprilysin are likely to play a 
role in envenomation. While acetylcholinesterase is known for reducing the amount of the 
neurotransmitter acetylcholine at synapses, neprilysin is a metalloprotease that might be involved in 
the degradation of extracellular matrix around synapses [9]. Thus, both enzymes might participate in 
prey envenoming and capture, with neprilysin aiding the action of acetylcholinesterase and neurotoxic 
peptides by facilitating their access to synaptic targets. 
3. Experimental Section 
3.1. Specimens 
Trittame loki specimens were collected from Cairns, Queensland, with all specimens collected 
within 100 meters of each other. 
3.2. Magnetic Resonance Imaging 
MRI was used to obtain a three-dimensional (3D) shape of the venom glands without intrusive 
dissection or sectioning techniques. For fixation, one specimen was anaesthetized by CO2 for 30 min 
and the entire prosoma placed in 4% NBF. Prior to imaging, NBF was removed by four one hour of 
washing steps in phosphate buffered saline (PBS) and incubated overnight in 0.1% Magnevist® (Bayer, 
Germany) in PBS. After removal of NBF, the sample was submersed in perfluoro-ether Fomblin 
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(Solvay Solexis, Italy) and placed under vacuum to prevent air artifacts. Imaging was performed on a 
16.4 T (700 MHz) vertical 89-mm-bore systems (Bruker BioSpin, Rheinstetten, Germany) using a 
Bruker Micro 2.5 gradient system (2.5 G/cm A) and transmit/receive radiofrequency coils with 
diameter of 10 mm quadrature birdcage resonator (M2M Imaging, Brisbane, Australia). Bruker 
ParaVision 5.0 software was used for image acquisition and anatomical images were acquired using a 
3D FLASH (Fast Low Angle Shot) gradient echo sequence. The imaging parameters were:  
TR/TE = 40/8 ms, flip angle 20°, 4–8 excitations. The field-of-view and matrix sized to fit the sample 
with the resulting voxels having 30 µm isotropic resolution. Total scan time was 12 h. MRI data was 
processed using Medical Imaging Processing, Analysis, and Visualization v6.0.0 (MIPAV) and 3D 
image segmentation, surface rendering and volumetric measurements of the glands were performed 
manually using ITK-SNAP. 
3.3. Transcriptome Construction 
Paired venom glands were dissected out and pooled from nine mature females on the fourth day 
after venom depletion by electrostimulation. Total RNA was extracted using the standard TRIzol Plus 
method (Invitrogen), and extracts were then enriched for mRNA using a RNeasy mRNA mini kit 
(Qiagen). mRNA was reverse transcribed, fragmented, and ligated to a unique 10-base multiplex 
identifier (MID) tag prepared using standard protocols and applied to one PicoTitrePlate (PTP) for 
simultaneous amplification and sequencing on a Roche 454 GS FLX + Titanium platform (Australian 
Genome Research Facility). Automated grouping and analysis of sample-specific MID reads 
informatically separated sequences from the other transcriptomes on the plates, which were then  
post-processed to remove low quality sequences before de novo assembly into contiguous sequences 
(contigs) using v3.4.0.1 of the MIRA software program. Assembled contigs were processed using CLC 
Main Work Bench (CLC-Bio) and the Blast2GO bioinformatic suite [17,18] to provide Gene 
Ontology, BLAST and domain/Interpro annotation. The above analyses assisted in rationalisation of 
the large numbers of assembled contigs into phylogenetic “groups” for detailed phylogenetic analyses 
as outlined below. Assembly of the data gave 4711 contigs from the 2,340,167 assembled bases, with 
an average of 497 bases per contig. The raw assembly has been deposited to the NCBI Bioproject 
repository with the accession number PRJNA189679. For individual sequences analysed in this study, 
Genbank accession numbers are GAQE00000001-GAQE00000047. It should be noted that only full 
length sequences were curated, while fragments were not included in the analyses. 
3.4. Bioinformatics 
3.4.1. Phylogenetics 
Toxin sequences were identified by comparison of the translated DNA sequences with those of 
previously characterised toxins using a BLAST search [19] implemented in the UniProtKB protein 
database. Phylogenetic analyses were conducted not only using the translated amino acid sequences 
recovered in this study, but also those already published, and the molecular evolutionary history of the 
T. loki ICK peptides was reconstructed. All sequences obtained in this study are indicated by their 
Genbank accession numbers and sequences from previous studies are referred to by their UniProtKB 
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accession numbers. Resultant sequence sets were aligned using CLC Main Work Bench, using the 
default algorithm. Sequence alignments are depicted with their signal peptide shown in lowercase and 
cysteines highlighted in bold. Datasets were analysed using a Bayesian inference implemented in 
MrBayes version 3.2.1 [20] and the command block lset rates = gamma with prset aamodelpr = mixed, 
which enables the program to optimize between nine different amino acid substitution matrices, was 
employed. The analysis was performed by running a minimum of 1 × 107 generations in four chains, 
and saving every 100th tree. The log-likelihood score of each saved tree was plotted against the 
number of generations to establish the point at which the log likelihood scores reached their asymptote, 
and the posterior probabilities for clades established by constructing a majority-rule consensus tree for 
all trees generated after completion of the burn-in phase. Supplementary File 2 contains alignment details. 
3.4.2. Test for Recombination 
Since phylogenetic and evolutionary interpretations [21] are influenced by recombination, we 
employed Single Breakpoint algorithm implemented in the HyPhy package and assessed the role of 
recombination on ICK peptide-encoding genes examined in this study [22,23]. When potential 
breakpoints were detected using the small sample Akaike information Criterion (AICc), the sequences 
were compartmentalized before conducting selection analyses. 
3.4.3. Selection Analyses 
We evaluated the influence of natural selection on the venom of the barychelid spider T. loki using 
maximum-likelihood models [24,25] implemented in CODEML of the PAML package [26]. We 
initially employed the one-ratio model that assumes a single ω for the entire phylogenetic tree. 
However, this model tends to be very conservative and can only detect positive selection when the ω 
ratio averaged over all the sites along the lineage is significantly greater than one. Since a  
lineage-specific model like the one-ratio model assumes a single ω for the entire tree, it often fails to 
identify regions in proteins that might be affected by episodic selection pressures and hence 
underestimates the strength of selection. We therefore employed site-specific models that estimate 
positive selection statistically as a non-synonymous-to-synonymous nucleotide-substitution rate ratio 
(ω) significantly greater than 1. We compared likelihood values for three pairs of models with different 
assumed ω distributions as no a priori expectation exists for the same: M0 (constant ω rates across all 
sites) versus M3 (allows ω to vary across sites within “n” discrete categories, n ≥ 3); M1a (a model of 
neutral evolution) where all sites are assumed to be either under negative (ω < 1) or neutral selection 
(ω = 1) versus M2a (a model of positive selection) which in addition to the site classes mentioned for 
M1a, assumes a third category of sites; sites with ω > 1 (positive selection) and M7 (Beta) versus M8 
(Beta and ω), and models that mirror the evolutionary constraints of M1 and M2 but assume that ω 
values are drawn from a beta distribution [27]. Only if the alternative models (M3, M2a and M8: allow 
sites with ω > 1) show a better fit in Likelihood Ratio Test (LRT) relative to their null models (M0, 
M1a and M7: do not allow sites with ω > 1), are their results considered significant. LRT is estimated 
as twice the difference in maximum likelihood values between nested models and compared with the 
χ2 distribution with the appropriate degree of freedom—the difference in the number of parameters 
between the two models. The Bayes empirical Bayes (BEB) approach [28] was used to identify amino 
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acids under positive selection by calculating the posterior probabilities that a particular amino acid 
belongs to a given selection class (neutral, conserved or highly variable). Sites with greater posterior 
probability (PP ≥ 95%) of belonging to the “ω > 1 class” were inferred to be positively selected. 
Single Likelihood Ancestor Counting (SLAC), Fixed-Effects Likelihood (FEL), and Random 
Effects Likelihood (REL) models [29] implemented in HyPhy [22] were employed to provide 
additional support to the aforementioned analyses and to detect sites evolving under the influence of 
positive and negative selection. Mixed Effects Model Evolution (MEME) [30] was also used to detect 
episodic diversifying selection. A complementary protein-level approach implemented in TreeSAAP [31] 
was used to assess the radicalness of mutations. The proportion of sites under different regimes of 
selection was depicted using an evolutionary fingerprint analysis, which uses an ESD algorithm, 
implemented in datamonkey [32]. We further employed branch-site REL to identify lineages 
undergoing episodic bursts of adaptation [33]. 
3.5. Proteomics 
Specimens were anaesthetized using carbon dioxide gas. Polyethylene equipment was used to 
collect and process samples in all cases. Samples were subsequently filtered using 20 Å syringe filters 
to remove large mucoidal strands and then lyophilised. Reduction and alkylation was undertaken by 
redissolving 3 µg of sample in 50 µL of 100 mM ammonium carbonate. 50 µL of 2% 
iodoethanol/0.5% triethylphosphine in acetonitrile was then added to the re-dissolved sample. The 
reaction mixture was incubated for 2 h at 37 °C, before being dried by vacuum centrifugation and  
re-suspended in 20 µL of 2.5% acetonitrile (ACN), 1% formic acid. Additionally, 3 µg of reduced and 
alkylated sample was resuspended in 20 µL of 40 mM ammonium bicarbonate, before being incubated 
overnight with 750 ng trypsin. Digestion was stopped by addition of 1 µL of concentrated formic acid. 
5 µL (0.75 µg) of each sample was processed by LC/MS using a Vydac Everest C18 column  
(150 mm × 7.5 mm, 5 mm particle size, 300 Å pore size) at a flow of 0.5 mL/min and a gradient of 
1%–40% solvent B (90% ACN, 0.1% formic acid) over 25 min coupled with an AB SCIEX 5600 
Triple TOF mass spectrometer. MS2 spectra were acquired at a rate of 20 scans/second. MS2 spectra 
were searched against the translated cDNA library using Proteinpilot v4.0 (ABSciex) and further 
analysed using CLC Main Workbench v6.6. 
4. Conclusions 
In conclusion, our multidisciplinary approach has revealed: (i) the differential rate of evolution 
adopted by T. loki toxins: some clades are extremely well conserved under the influence of negative 
selection, likely as a result of the steric requirements that influence binding efficiencies, while others 
rapidly accumulate variations under positive selection; (ii) the evolution of novel molecular scaffolds 
through the acquisition of new cysteine residues; (iii) the important role of positive selection in the 
evolution and diversification of ICK/knottin toxin clades; (iv) the presence of novel enzymes 
(acetylcholinesterase and neprilysin) for the first time in spider venom; and (v) the presence of CAP 
for the first time in the mygalomorph spider venom. Venom components employed for predation often 
experience a greater influence from positive selection and accumulate variations that are not only 
necessary for acquiring different types of prey [34–36], but also in escaping host immune responses [37]. 
Toxins 2013, 5 2501 
 
 
The likelihood of identifying novel venom components for drug design is theoretically higher in 
organisms with extremely variant and rapidly evolving venom arsenals. The results of this study 
reinforce the significance of studying even obscure spider lineages. These results also add to the 
growing body of knowledge regarding structural convergence of venom components as both 
acetylcholinesterase and neprilysin have been recruited into the venoms of other animals [36,37]. 
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